PGRMC1 originally was identified by expression induction during carcinogenesis in liver cancer (Nie et al., 2006), and recently was observed its elevation with tumor stage in ovarian cancer and estrogen receptor-negative breast cancer (Neubauer et al., 2008). This evidence concerns the gene ESR1 and neoplasm.